EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.

$2.02  0.00 (0.00%)
As of 05/20/2022 16:30:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/25/2018
Outstanding shares:  33,568,554
Average volume:  154,198
Market cap:   $67,808,479
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -36.49
PB ratio:   2.15
PS ratio:   5.65
Return on equity:   -49.56%
Net income %:   -123.05%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy